Clinical and point-of-care (POC) diagnostics demand:
Enzyme performance is often the limiting factor in assay sensitivity and reliability.
Neoncorte Bio develops AI-optimized enzymes tailored for next-generation biosensor platforms in clinical and decentralized diagnostic settings.